Baron Wealth Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,822
Closed -$258K 141
2023
Q2
$258K Buy
2,822
+21
+0.7% +$1.72K 0.16% 108
2023
Q1
$206K Hold
2,801
0.15% 127
2022
Q4
$234K Buy
+2,801
New +$253K 0.18% 109

Other funds holding AMED

Baron Wealth Management's AMED Position: Q3 2023 in Review

Baron Wealth Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,822 shares — an estimated $258K sold.

Baron Wealth Management first reported a position in AMED in Q4 2022 and held it in 3 quarters. The position peaked at $258K in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Baron Wealth Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Baron Wealth Management sold 2,822 Amedisys shares in Q3 2023, an estimated $258K.
  • Baron Wealth Management first reported a position in Amedisys in Q4 2022 and held it in 3 quarters.
  • Baron Wealth Management's Amedisys position peaked at $258K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Baron Wealth Management's 13F filing for Q3 2023, filed 1 Nov 2023.